Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Bone marrow involvement in Burkitt's lymphoma

R D Brunning, R W McKenna, C D Bloomfield

    Cancer
    |October 1, 1977
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    [Total parathyroidectomy, autoimplant and cryopreservation for the treatment of hyperparathyroidism of renal origin in children and young adults].

    Cirugia pediatrica : organo oficial de la Sociedad Espanola de Cirugia Pediatrica·2018
    Same author

    No evidence for microsatellite instability in acute myeloid leukemia.

    Leukemia·2017
    Same author

    The mutational oncoprint of recurrent cytogenetic abnormalities in adult patients with de novo acute myeloid leukemia.

    Leukemia·2017
    Same author

    Mutations in the CCND1 and CCND2 genes are frequent events in adult patients with t(8;21)(q22;q22) acute myeloid leukemia.

    Leukemia·2016
    Same author

    Maintenance therapy with decitabine in younger adults with acute myeloid leukemia in first remission: a phase 2 Cancer and Leukemia Group B Study (CALGB 10503).

    Leukemia·2016
    Same author

    Adult acute myeloid leukemia with trisomy 11 as the sole abnormality is characterized by the presence of five distinct gene mutations: MLL-PTD, DNMT3A, U2AF1, FLT3-ITD and IDH2.

    Leukemia·2016

    Burkitt's lymphoma frequently involves bone marrow in young patients, often presenting without typical leukemia signs. Despite intensive treatment, the prognosis remains poor, with a median survival of 2.5 months after marrow involvement detection.

    Area of Science:

    • Hematology
    • Oncology
    • Pediatric Oncology

    Background:

    • Malignant lymphoma with Burkitt's lymphoma cytologic characteristics can present with bone marrow involvement.
    • Bone marrow involvement is a critical prognostic factor in lymphomas.

    Purpose of the Study:

    • To describe the clinical characteristics and outcomes of patients with Burkitt's lymphoma and bone marrow involvement.
    • To analyze the presentation, hematologic findings, and survival in this patient cohort.

    Main Methods:

    • Retrospective analysis of 13 patients with Burkitt's lymphoma and confirmed bone marrow involvement.
    • Evaluation of clinical data, including age, disease site, blood counts, and surface marker studies.
    • Assessment of treatment response and survival duration.

    Related Experiment Videos

    Main Results:

    • Bone marrow involvement was observed at diagnosis in 11 patients and later in 2.
    • Most affected patients were 16 years or younger, with abdominal disease common.
    • Leukemic blood pictures, low platelet, and neutrophil counts were infrequent despite extensive marrow infiltration.
    • Median survival after detecting marrow involvement was 2.5 months, indicating a poor prognosis.

    Conclusions:

    • Bone marrow involvement in Burkitt's lymphoma, particularly in pediatric patients, is associated with a rapid clinical course and poor survival.
    • The absence of leukemic blood pictures does not preclude extensive marrow infiltration and warrants careful hematologic evaluation.
    • Further research into novel therapeutic strategies is needed for this aggressive lymphoma subtype.